Aim: In this cohort, we aimed to study the evolution of pregenomic RNA (pgRNA) during treatment and compare it with other disease scores such as FIB-4 and PAGE-B.Methods: Eighty-eight HBeAg negative CHB who received long-term treatment with NAs were included. A quantitative HBV S antigen (HBsAg) assay was performed, and viral HBV DNA was quantified… Continue reading Is there any role for #HBV pgRNA in #fibrosis and #HCC predisposition?
Author: aledopress
Medicine and Technology enthusiast..
#Statins and clinical outcomes in patients with advanced #hepatocellular carcinoma treated with #Atezolizumab plus #Bevacizumab
The impact of statins on patients receiving immune checkpoint inhibitors for advanced hepatocellular carcinoma (aHCC) remains unclear. This study aimed to evaluate whether statins influence overall survival (OS) and progression-free survival (PFS) in aHCC patients receiving Atezolizumab + Bevacizumab (A + B). ARTE is a prospectively maintained dataset of 305 aHCC patients treated with A… Continue reading #Statins and clinical outcomes in patients with advanced #hepatocellular carcinoma treated with #Atezolizumab plus #Bevacizumab
Multicentre, double-blind, randomized placebo-controlled trial to evaluate the therapeutic efficacy of #nutraceutical combination in the treatment of #allergic #rhinitis
BackgroundAllergic rhinitis (AR) is a widely diffused atopic disease that is hardly managed by conventional therapy, especially in the long-term. Fatty acids (FAs), which possess both anti-inflammatory and immunomodulatory properties, could be used to control AR symptoms.ObjectiveWe aimed at evaluating the benefits (efficacy in reducing symptoms and safety) of using an oral supplement containing FAs… Continue reading Multicentre, double-blind, randomized placebo-controlled trial to evaluate the therapeutic efficacy of #nutraceutical combination in the treatment of #allergic #rhinitis
Treatment patterns of #romosozumab in postmenopausal women with severe #osteoporosis in Denmark: findings from the ROmosozumab in Scandinavia real-world Evidence Study (ROSES)
To describe patient and prescriber characteristics and factors associated with utilization of romosozumab in Denmark.MethodsThis registry‑based Danish retrospective cohort study comprised females aged ≥ 50 receiving osteoporosis medication from September 2020 − October 2023. Three cohorts were identified: those treated with romosozumab (cohort 1), those with osteoporosis‑related fracture within the last three years treated with other osteoporosis medications (cohort… Continue reading Treatment patterns of #romosozumab in postmenopausal women with severe #osteoporosis in Denmark: findings from the ROmosozumab in Scandinavia real-world Evidence Study (ROSES)
#Amino acid metabolites as potential circulating biomarkers for #sarcopenia
Sarcopenia, characterized by the loss of muscle mass and strength, is a multifactorial disorder, including metabolic disturbance. Plasma amino acids (AAs) regulate muscle protein synthesis and breakdown. This study evaluated plasma AA metabolites as potential biomarkers for sarcopenia using metabolomic analysis. We assessed 31 AA metabo lites in an age-matched discovery cohort (72 men, 36… Continue reading #Amino acid metabolites as potential circulating biomarkers for #sarcopenia
Associations of #Wearable- Measured #Sleep and #Physical Activity With #Memory Performance in Older Adults: Cross-Sectional Study With Actigraphy and MRI
Background: Cognitive decline is a common aspect of aging, and identifying modifiable lifestyle factors-such as physical activity and sleep-are crucial for promoting healthy brain aging. While both are individually linked to cognition, few studies have simultaneously assessed their independent and combined effects using objective wearable-based data, particularly in older Asian populations.Objective: This study aimed to… Continue reading Associations of #Wearable- Measured #Sleep and #Physical Activity With #Memory Performance in Older Adults: Cross-Sectional Study With Actigraphy and MRI
Factors associated with the failure to achieve nocturnal blood #pressure control
Background: The Hiroshima Registry for Evaluation and Treatment of Nocturnal and Early Morning Hypertension (Hiroshima NOCTURNE) was a prospective, multicenter study designed to determine whether elevated nighttime blood pressure (BP), assessed using a home BP monitoring (HBPM) device, can be normalized through active antihypertensive therapy in patients already receiving antihypertensive medication. In this subanalysis, we… Continue reading Factors associated with the failure to achieve nocturnal blood #pressure control
Association Between Wake-Time #Movement Behaviors and #Weight Loss Maintenance
We examined whether wake-time movement composition was associated with weight loss maintenance among individuals who experienced clinically meaningful weight loss (> 5% of initial weight) using compositional data analysis.MethodsThis was a secondary analysis from a behavioral weight loss maintenance intervention on weight regain over 12 months following clinically meaningful 3-month weight loss. Body weight was assessed… Continue reading Association Between Wake-Time #Movement Behaviors and #Weight Loss Maintenance
#Adenosine as the metabolic common path of rapid #antidepressant action: The #coffee paradox
Yue, Luo, and colleagues discovered that adenosine signalling is the common underlying mechanism of rapid acting antidepressant therapies, unifying the effects of ketamine, ECT and acute intermittent hypoxia. They use genetically encoded sensors, along with extensive mechanistic dissection, to show that all three induce adenosine surges in mood-regulatory circuits via A1 and A2A receptor activation.… Continue reading #Adenosine as the metabolic common path of rapid #antidepressant action: The #coffee paradox
2 Medical News 